Intrinsic Value of S&P & Nasdaq Contact Us

Masimo Corporation MASI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
50/100
4/7 Pass
SharesGrow Intrinsic Value
$80.47
-54.9%
Analyst Price Target
$187.50
+5.1%

Masimo Corporation (MASI) — Analyst outlook / Analyst consensus target is. Based on 23 analyst ratings, the consensus is bullish — 14 Buy, 9 Hold.

The consensus price target is $187.50 (low: $180.00, high: $200.00), representing an upside of 5.1% from the current price $178.39.

Analysts estimate Earnings Per Share (EPS) of $1.50 and revenue of $2.02B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-5.72 vs est $1.50 (missed -481.8%). 2025: actual $-2.83 vs est $4.03 (missed -170.2%). Analyst accuracy: 0%.

MASI Stock — 12-Month Price Forecast

$187.50
▲ +5.11% Upside
Average Price Target
Based on 23 Wall Street analysts offering 12-month price targets for Masimo Corporation, the average price target is $187.50, with a high forecast of $200.00, and a low forecast of $180.00.
The average price target represents a +5.11% change from the last price of $178.39.
Highest Price Target
$200.00
Average Price Target
$187.50
Lowest Price Target
$180.00

MASI Analyst Ratings

Buy
23
Ratings
14 Buy
9 Hold
Based on 23 analysts giving stock ratings to Masimo Corporation in the past 3 months
Rating breakdown
Buy
14 61%
Hold
9 39%
61%
Buy
14 analysts
39%
Hold
9 analysts
0%
Sell
0 analysts

EPS Estimates — MASI

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$5.72 vs Est $1.50 ▼ 126.2% off
2025 Actual –$2.83 vs Est $4.03 ▼ 242.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.

Revenue Estimates — MASI

80%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $2.094B vs Est $2.017B ▲ 3.7% off
2025 Actual $1.527B vs Est $2.086B ▼ 36.6% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message